Infectious Diseases in Obstetrics and Gynecology Conﬂict of Interests The authors declare no conﬂict of interests. Acknowledgments This study was conducted at the Postgraduation in Medicine and Human Health program of Escola Bahiana de Medicina e Sau´ de Pu´ blica-EBMSP, Salvador, Bahia, Brazil, and funded by the Fundac¸ a˜o de Amparo a` Pesquisa do Estado da Bahia (Fapesb), Bahia, Brazil. The authors thank Cibele A Souza and Marina Borba Moreira, for technical assistance and Paula Matos, M.D., for critically reading and assisting in the writing of this paper. References [1] World Health Organization, “Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections Overview and Estimates,” New York, NY, USA, 2001. [2] V. D. A. Tanaka, L. J. Fagundes, A. Catapan, S. L. D. Gotlieb, W. Belda Jr., M. Arnone et al., “Perﬁl epidemiolo´ gico de mulheres com vaginose bacteriana, atendidas em um ambulato´ rio de doenc¸as sexualmente transmiss´ıveis, em Sa˜o Paulo, SP,” Anais Brasileiros de Dermatologia, vol. 82, no. 1, pp. 41–46, 2007. [3] J. Wang, “Bacterial vaginosis,” Primary Care Update for Ob/Gyns, vol. 7, no. 5, pp. 181–185, 2000. [4] T. S. Syed and P. K. Braverman, “Vaginitis in adolescents,” Adolescent Medicine Clinics, vol. 15, no. 2, pp. 235–251, 2004. [5] P. Nyirjesy, “Vaginitis in the adolescent patient,” Pediatric Clinics of North America, vol. 46, no. 4, pp. 733–745, 1999. [6] H. Verstraelen, R. Verhelst, M. Vaneechoutte, and M. Tem- merman, “The epidemiology of bacterial vaginosis in relation to sexual behaviour,” BMC Infectious Diseases, vol. 10, no. 1, article 81, 2010. [7] M. Morris, A. Nicoll, I. Simms, J. Wilson, and M. Catchpole, “Bacterial vaginosis: a public health review,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 108, no. 5, pp. 439–450, 2001. [8] A. M. Geiger, B. Foxman, and B. W. Gillespie, “The epidemi- ology of vulvovaginal candidiasis among university students,” American Journal of Public Health, vol. 85, no. 8, part 1, pp. 1146–1148, 1995. [9] J. P. Trama, M. E. Adelson, I. Raphaelli, S. M. Stemmer, and E. Mordechai, “Detection of Candida species in vaginal samples in a clinical laboratory setting,” Infectious Diseases in Obstetrics and Gynecology, vol. 13, no. 2, pp. 63–67, 2005. [10] H. L. Kent, “Epidemiology of vaginitis,” American Journal of Obstetrics & Gynecology, vol. 165, no. 4, part 2, pp. 1168–1176, 1991. [11] K. A. Fethers, C. K. Fairley, J. S. Hocking, L. C. Gurrin, and C. S. Bradshaw, “Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis,” Clinical Infectious Diseases, vol. 47, no. 11, pp. 1426–1435, 2008. [12] M. Vaca, I. Guadalupe, S. Erazo et al., “High prevalence of bacterial vaginosis in adolescent girls in a tropical area of Ecuador,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 117, no. 2, pp. 225–228, 2010. [13] D. M. T. Faustini, N. F. Novo, M. C. F. D. S. Cury, and Y. Juliano, “Programa de orientac¸a˜o desenvolvido com adolescentes em centro de sau´ de: conhecimentos adquiridos 5 sobre os temas abordados por uma equipe multidisciplinar,” Ciˆencia & Sau´de Coletiva, vol. 8, no. 3, pp. 783–790, 2003. [14] J. W. Krashin, E. H. Koumans, A. C. Bradshaw-Sydnor et al., “Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population,” Sexually Transmitted Diseases, vol. 37, no. 7, pp. 440–444, 2010. [15] “Adolescence, an Age of Opportunity: The State of the World’s Children 2011,” New York, NY, USA, United Nations Children’s Fund, 2011. [16] R. P. Nugent, M. A. Krohn, and S. L. Hillier, “Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation,” Journal of Clinical Microbiology, vol. 29, no. 2, pp. 297–301, 1991. [17] M. D. S. Wanderley, E. M. S. Magalha˜es, and E´. R. Trindade, “Avaliac¸a˜o Cl´ınica e Laboratorial de Crianc¸as e Adolescentes com Queixas Vulvovaginais,” Revista Brasileira de Ginecologia e Obstetr´ıcia, vol. 22, no. 3, pp. 147–152, 2000. [18] M. M. Barousse, B. J. Van Der Pol, D. Fortenberry, D. Orr, and P. L. Fidel Jr., “Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents,” Sexually Transmitted Infections, vol. 80, no. 1, pp. 48–53, 2004. [19] M. S. Almeida, D. S. Argoˆ lo, J. S. Almeida Ju´ nior, M. S. Pinheiro, and A. M. G. D. Brito, “Tricomon´ıase: prevaleˆncia no geˆnero feminino em Sergipe no bieˆnio 2004–2005,” Ciˆencia & Sau´de Coletiva, vol. 15, supplement 1, pp. 1417–1421, 2010. [20] C. G. Luppi, R. L. S. D. Oliveira, M. A. Veras, S. A. Lippman, H. Jones, C. H. D. Jesus et al., “Diagno´ stico precoce e os fatores associados a`s infecc¸ o˜es sexualmente transmiss´ıveis em mulheres atendidas na atenc¸a˜o prima´ria,” Revista Brasileira de Epidemiologia, vol. 14, no. 3, pp. 467–477, 2011. [21] U. Karaman, N. Karadagˇ, M. Atambay, N. B. Arserim Kaya, and N. U. Daldal, “A comparison of cytological and parasito- logical methods in the diagnosis of Trichomonas vaginalis,” Turkiye Parazitol Derg, vol. 32, no. 4, pp. 309–312, 2008. [22] A. M. Caliendo, J. A. Jordan, A. M. Green, J. Ingersoll, R. J. Diclemente, and G. M. Wingood, “Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs,” Infectious Diseases in Obstetrics and Gynecology, vol. 13, no. 3, pp. 145–150, 2005. [23] M. Sutton, M. Sternberg, E. H. Koumans, G. McQuillan, S. Berman, and L. Markowitz, “The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001–2004,” Clinical Infectious Diseases, vol. 45, no. 10, pp. 1319–1326, 2007. [24] R. Crosby, R. J. DiClemente, G. M. Wingood et al., “Predictors of infection with Trichomonas vaginalis: a prospective study of low income African-American adolescent females,” Sexually Transmitted Infections, vol. 78, no. 5, pp. 360–364, 2002. [25] E. Rylander, A. L. Berglund, C. Krassny, and B. Petrini, “Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse,” Sexually Transmitted Infections, vol. 80, no. 1, pp. 54–57, 2004. [26] M. S. Cohen, I. F. Hoﬀman, R. A. Royce et al., “Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1,” The Lancet, vol. 349, no. 9069, pp. 1868–1873, 1997. [27] M. Laga, A. Manoka, M. Kivuvu et al., “Non-ulcerative sexu- ally transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study,” AIDS, vol. 7, no. 1, pp. 95–102, 1993. [28] K. Chaijareenont, K. Sirimai, D. Boriboonhirunsarn, and O. Kiriwat, “Accuracy of Nugent’s score and each Amsel’s criteria